Advanced glycation end products: a highly complex set of biologically relevant compounds detected by mass spectrometry.
暂无分享,去创建一个
A. Lapolla | D. Fedele | D. Favretto | R. Seraglia | P. Traldi | R Seraglia | P Traldi | A Lapolla | D Fedele | L Martano | N C Arico' | M Garbeglio | D Favretto | M. Garbeglio | L. Martano | N. C. Aricò | Domenico Fedele | A. Lapolla | Pietro Traldi
[1] C. Gerhardinger,et al. Investigation of products arising from enzymatic digestion of advanced glycated albumin by high-performance liquid chromatography/mass spectrometry. , 1991, Rapid communications in mass spectrometry : RCM.
[2] A. Gugliucci,et al. Circulating advanced glycation peptides in streptozotocin-induced diabetic rats: evidence for preferential modification of IgG light chains. , 1998, Life sciences.
[3] J. Baynes,et al. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.
[4] C van Ypersele de Strihou,et al. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. , 1999, Kidney international.
[5] R. Bucala,et al. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[6] R. Flückiger,et al. Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. , 1986, The Journal of biological chemistry.
[7] K Nakamura,et al. Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. , 1997, Biochemical and biophysical research communications.
[8] V. Monnier,et al. Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. , 1987, Carbohydrate research.
[9] R. Dean. Lysosomal enzymes as agents of turnover of soluble cytoplasmic proteins. , 1975, European journal of biochemistry.
[10] S. Grundy,et al. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Lapolla,et al. The in vitro glycation of lysozyme and the influence of buffer concentration investigated by mass spectrometry. , 1996, Rapid communications in mass spectrometry : RCM.
[12] Paul J Thornalley. THE CLINICAL SIGNIFICANCE OF GLYCATION , 1999 .
[13] A. Lapolla,et al. Evaluation of IgG glycation levels by matrix-assisted laser desorption/ionization mass spectrometry. , 1997, Rapid communications in mass spectrometry : RCM.
[14] E. Friedman,et al. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure , 1994, The Lancet.
[15] K. Maeda,et al. Mass spectrometric study on the protein chemical modification of uremic patients in advanced Maillard reaction. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[16] R. Bucala,et al. Immunochemical detection of advanced glycosylation end products in vivo. , 1992, The Journal of biological chemistry.
[17] F. Hayase,et al. 3-Deoxyglucosone Crosslinks Proteins under Physiological Conditions , 1987 .
[18] E. Diamandis,et al. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. , 1994, Kidney international.
[19] C. Gerhardinger,et al. A study on in vitro glycation processes by matrix-assisted laser desorption ionization mass spectrometry. , 1993, Biochimica et biophysica acta.
[20] V. Monnier,et al. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. , 1981, Science.
[21] S P Wolff,et al. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.
[22] V. Monnier,et al. Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDM , 1992, Diabetes.
[23] J. Baynes,et al. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. , 1986, The Journal of biological chemistry.
[24] E. Friedman,et al. Advanced glycosylation end products in patients with diabetic nephropathy. , 1991, The New England journal of medicine.
[25] J. Yates,et al. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.
[26] R. Rolandi,et al. Prevention of Diabetes-Increased Aging Effect on Rat Collagen-Linked Fluorescence by Aminoguanidine and Rutin , 1990, Diabetes.
[27] H. Sano,et al. Advanced Glycation End Products and Their Recognition by Macrophage and Macrophage-Derived Cells , 1996, Diabetes.